Abstract We describe two children with significant bleeding: one with multiple ecchymoses and the other with scrotal bleeding. In both patients, the activated partial thromboplastin time (APTT) was prolonged, with positivity for lupus anticoagulants (LA). However, the Owren prothrombin time (PT), usually insensitive for LA, was also prolonged. The presence of LA is associated with diverse clinical manifestations, with most patients being asymptomatic while others present venous or arterial thrombosis. Bleeding in conjunction with LA is rare and it is unusual to see prolongation of the Owren PT assay due to LA. An extended laboratory investigation of one of the patient's plasma revealed not only LA but also a specific nonphospholipiddependent antiprothrombin antibody causing an acquired hypoprothrombinemia. Conclusion: It is likely that the low prothrombin activity and not the LA caused the bleeding. The bleeding signs and symptoms in both patients subsided when the PT was normalized, although the prolonged APTT and the LA remained.
Introduction
Antiphospholipid antibodies, of which lupus anticoagulants (LA) is the most well-known, comprise a heterogeneous group of antibodies directed against phospholipids and negatively charged phospholipid-protein complexes [4, 13, 14, 18] . In children, LA diagnosis is often incidental, frequently after investigation of prolonged activated partial thromboplastin time (APTT) prior to surgery or in conjunction with viral infections. Usually, these antibodies are transient and clinically irrelevant and, most importantly, do not cause bleeding. It is reported that 3 % of healthy children undergoing routine presurgical screening have isolated prolonged APTT due to transient circulating antibodies [13, 14] . However, it has been demonstrated that LA represents a higher risk of thrombosis than other antiphospholipid antibodies [3] and LA has also been related with stroke and cerebral venous thrombosis in children [1, 2, 24] . Viral infections might be responsible for transient LA and for thrombotic events [21] .
Prothrombin has been proposed as an important phospholipid-bound antigenic target of LA, but the existence of and clinical relevance of specific antiprothrombin antibodies is controversial [7, 15, 17, 25, 30] . Phospholipid-independent antiprothrombin antibodies, in the absence of LA, has also been associated with pediatric thrombosis [28] . Thus, antibodies against the procoagulant prothrombin, with or without LA, may increase thrombosis risk, but the mechanism is unclear.
In addition, there have been cases with acquired hypoprothrombinemia and bleeding, most often in combination with LA [5, 6, 8-12, 20, 22, 27, 32, 33] . Hemorrhagic LA syndrome is rare, with <30 patients described in the medical literature, and it has been attributed to increased clearance of prothrombin caused by non-neutralizing antiprothrombin antibodies. Their signs and symptoms have varied from mild bleeding such as bruising and hematoma to severe gum bleeding, epistaxis, and in two cases, hemarthrosis [5, 6, 8-12, 20, 22, 27, 32, 33] . Autoimmune disease, e.g., systemic lupus erythematosus (SLE), appears to be associated with LA and antiprothrombin antibodies, but only few children had concomitant SLE [6, 9, 20] . Most patients had no underlying autoimmune disorder and, in half of these patients, the bleeding was preceded by a viral infection either respiratory or gastrointestinal; in half of the patients, adenovirus was found. All of these patients were below 11 years of age and none of them developed an autoimmune or vasculitis disorder in conjunction with or in the observation period after the episode. All recovered within approximately 3 months with or without treatment.
We describe two patients with hemorrhagic signs and symptoms in conjunction with LA, in both preceded by adenoviral infections. The bleeding in both patients subsided when the prothrombin time (PT) was normalized, although the prolonged APTT and the LA persisted. In one of the patients, plasma was available for additional testing and we could show that the PT prolongation was due to nonphospholipid-dependent prothrombin antibodies. Prothrombin (factor II) is converted into thrombin and is an important coagulation factor in the common pathway of the classical coagulation pathway [19] . It is likely that the low prothrombin activity and not the LA caused the bleeding signs and symptoms.
Materials and methods
Venous blood for coagulation analysis was collected in 5-mL vacuum tubes containing 0.5 mL of sodium citrate (0.129 M). The blood was centrifuged at 3,600 × g for 10 min within 30 min of collection, and the plasma was frozen in aliquots at −70°C until use. The investigation was performed using standard methods to determine the following: Quick and Owren PT assays, APTT, free PS, antithrombin, protein C, factors (F)VIII, FIX, FXI, and VWF both activity and antigen. The Quick PT was determined with a plain PT reagent, Thromborel S (Siemens, Marburg, Germany), and reported in seconds, whereas the Owren PT was determined with a combined PT reagent SPA + (Stago, Asniéres sur Seine, France) and the results were given in international normalized ratio (INR). In general, the Owren PT assay is less affected by interfering substances in plasma, such as LA, as the final dilution of plasma is 1:21 compared to 1:3 for the Quick PT assay. LA was detected by an integrated test system based on the dilute Russell's viper venom time (dRVVT) using LA1 screening and LA2 confirmation test (Siemens). A dRVVT ratio (LA1 screen/LA2 confirmation) above 1.5 was established locally as an LA-positive result. A quantitative enzyme-linked immunosorbent assay (ELISA) kits were used for detecting anticardiolipin antibodies (ACA) IgG (Orgentec Diagnostika, Mainz, Germany) according to the manufacturers' instructions.
In addition, an in-house quantitative ELISA was employed to determine antiprothrombin autoantibodies in stored samples as previously described [28] . All samples were run in duplicate, and mean optical density (OD) values were calculated for blank (no sample), patient samples, and positive and negative controls. The mean OD and standard deviation (SD) for 10 healthy controls was calculated on each plate. The obtained ODs for samples were then expressed as the number of SD above the mean of the healthy controls. The cutoff for a positive result was set at +3 SD.
Case reports and results

Patient 1
An 11-year-old boy presented with a scrotal hematoma after light trauma, and bleeding become more extensive after surgical exploration and continued post surgery. This was not preceded by an obvious infection, but there had been short fever and loose stools a couple of weeks earlier. He had no family history of bleeding disorder and no prior history of spontaneous bleeding except a large hematoma, 3 cm in diameter, in his forehead after light trauma 1 week earlier. His medical history included a post infectious glomerulonephritis, and he had attention deficit hyperactivity disorder, treated with methylphenidate and atomoxetine. On admission, he was well, afebrile, and without lymphadenopathy or hepatosplenomegaly. He had no bruising but had large bilateral hematomas and extensive swelling of the scrotum. Laboratory studies showed a normal complete blood count with normal liver and renal function. Coagulation screening revealed prolonged PT, both the Owren-type PT assay expressed as INR and the Quick PT given in seconds, and APTT (Table 1) . Investigations were also positive for LA but no ACA, which could explain the prolonged APTT, but Owren PT of INR 3 is rarely associated with LA. Factor assays showed a low prothrombin level and factors FIX and FXI were not measurable due to assay interference with LA. All other coagulations test including FVIII (chromogenic assay), VWF, and thrombocyte function was normal. Furthermore, he tested negative for autoimmune markers (i.e., antinuclear antibodies). He received vitamin K and fresh frozen plasma as empirical therapy the day after surgery. It seemed to partially correct his coagulopathy. However, once the diagnosis had been established, no further plasma replacement was administered.
Over the following week, his scrotal hematoma cleared but did not completely heal or stop oozing. Therefore, 1 week after diagnosis, he received one dose of IVIG (1 g/ kg) due to prolonged bleeding or lack of wound healing. His Owren PT had already by then returned to normal, but his APTT was still prolonged and a strong positivity for LA remained. Thereafter, the signs and symptoms resolved completely and he has had no other bleeding signs or symptoms during the 6-month observation period. He tested positive for IgM and IgG for adenovirus, indicating a recent infection. Repeat coagulation studies 3 months after the initial presentation (day 107) showed no evidence of the LA and the APTT and PT, both Owren and Quick assays, remained normal (Table 1 ). The presence of LA made what has been called hemorrhagic lupus a plausible diagnosis. The cause of the hemorrhagic signs and symptoms was not likely to be the LA in itself since the bleeding stopped long before LA titers were normalized and the PT prolongation correlated well to the bleeding signs and symptoms. To further support the cause of bleeding, we could show nonphospholipiddependent prothrombin antibodies that disappeared when the bleeding ceased and the prothrombin level increased.
Patient 2
A 4-year-old girl presented with a history of lethargy and bruising over several months, with bruising becoming more extensive over this time. She had neither a prior history of spontaneous bleeding nor any significant heredity for bleeding disorders. The girl had asthma but was otherwise previously healthy.
On examination, she was well, afebrile, and had no lymphadenopathy or hepatosplenomegaly. She had extensive bruising over the bony prominences of her limbs and shoulders. She had no evidence of ongoing infection. The initial clinical impression was of malignancy or possibly a battered child. Laboratory studies showed a normal full blood count and platelets with normal liver and renal function. Coagulation screening revealed prolonged PT and APTT. Investigations revealed a positive LA and but no ACA. Factor assay showed a low prothrombin level and FIX and FXI were not measurable due to interference with LA. Factors VIII and VWF and bleeding time were normal. Her antinuclear antibody was negative. She tested positive for adenovirus in stool and blood. She received high-dose steroids starting with 10 mg three times daily, tapered out, and discontinued after a month. During that time, her coagulopathy was corrected. Over the following weeks, her bruising cleared and first her PT and later also the APTT returned to normal. Repeat coagulation studies 3 months after initial presentation showed no evidence of the LA and the prothrombin deficiency had completely resolved already after 2 weeks. This, in addition to the absence of antinuclear antibody and the transient presence of high-titer LA, made it likely a virally caused hemorrhagic syndrome rather than a more generalized autoimmune disorder. Although this patient was not tested for nonphospholipid prothrombin antibodies, in her case, the bleeding signs and PT were also normalized, but she remained positive for LA for approximately two additional months.
Discussion
Acquired antibodies of coagulation were first recognized in adults with autoimmune diseases, drug sensitivity, allergic disorders, and malignancy or in women postpartum. Antiphospholipid antibodies are recognized as the most common cause of acquired thrombophilia in adults and children [29] . In children, they tend to appear transiently after viral infections and, in contrast to what is seen in adults, they are usually not associated with other underlying disorders but can occur in conjunction with SLE or malignancy [13, 14] . Although rare, there are reports on children who present with bleeding related to circulating antibodies [5, 6, 8-12, 20, 22, 27, 32, 33] . The presentations described vary from all forms of mucosal and nonmucosal bleeding-bloody diarrhea, epistaxis, menorrhagia, purpura, macroscopic hematuria, bruising, or spontaneous hematoma formation. Sporadic case reports suggest that viral illness may be an etiological factor [31, 32] . Adenovirus has been implicated in most of the reported cases [20] , but other viruses such as varicella, cytomegalovirus, and Epstein-Barr virus have been associated. Both our patients tested positive for adenovirus. Both patients were treated with immunemodulating therapy (IVIG and steroids, respectively), which may have shortened the period of bleeding.
It is known that hypoprothrombinemia may occur in patients with LA and Bajaj et al. have suggested that it is due to the fact that LA forms complexes with circulating prothrombin [6] . Specific antibodies towards prothrombin have strangely enough been associated with both thrombosis and bleeding. It is not fully understood how autoantibodies against a procoagulant protein can result in a thrombosis phenotype. It has been suggested that these autoantibodies can enhance the binding of prothrombin to damaged endothelial cells, which leads to an enhanced thrombin formation [26, 34] . In vitro experiments have shown that antiprothrombin IgG can interfere with the inactivation of activated FV by activated protein C, which might result in a hypercoagulable state [16] . It is also possible that antiprothrombin antibodies has a prothrombotic effect due to their capacity to bind to thrombin and thereby protect it from downregulation by its natural regulator antithrombin [23] .
It is also not currently understood why some children with LA present with clinically significant bleeding while most do not. It has been postulated and is logical that the presence of antiprothrombin antibodies may be the determinant, but not all patients with a positive LA screen and antiprothrombin antibodies will develop hypoprothrombinemia and bleeding. Thus, the same type of antiprothrombin ELISA will detect both procoagulant and anticoagulant autoantibodies in a nonphospholipid manner and the ELISA by itself cannot discriminate between the two clinical phenotypes. It is unusual that the PT assay is affected even if these antibodies can be detected. In the two cases with bleeding described here, it was the effect on the LAinsensitive PT assays that draw our attention to possibility that there might be a more significant hypoprothrombinemia, probably caused by a specific autoantibody, which caused the bleeding problems and not the LA. The hypoprothrombinemia of both cases were clearly seen when the PT-derived one-stage prothrombin assay (FII:C) was applied. The specificity for prothrombin was also shown when the other two PTderived one-stage assays, based on the same PT reagent, resulted in normal levels of FVII:C and FX:C, respectively. The laboratory picture shown in case 1 is, however, complicated by the strong LA and its effect on the APTT-based onestage assays and it may be easy to generalize that all observed coagulation assay abnormalities are caused by interfering LA.
However, LA associated with thrombosis rarely affects the PT assays. In a retrospective survey of 917 consecutive positive LA patients (mainly adults) in our laboratory registry, only 1 case with a moderately high Owren PT/INR result (1.7) not caused by warfarin therapy could be detected. All patients were referred to our center for a venous thrombosis investigation, indicating that the type of antiprothrombin antibodies that results in a hypoprothrombinemia generating a high PT/INR is not associated with thrombosis, at least not in an adult population. However, there is an apparent association between hemorrhagic LA and hypoprothrombinemia with a prolonged PT, at least in children.
The case reports and the laboratory testing shed light on the finding that an acquired hemorrhagic disorder is a difficult diagnosis both clinically and laboratory-wise. A correct diagnosis and cause of bleeding is important, guiding continued care and treatment of the patients, especially since LA may remain several months after the cause of bleeding has disappeared. The finding of LA in children is not rare and the treating physician should be aware of the possible hemorrhagic complications in children with LA, especially if the PT assay is affected.
